Search results for " injury"

showing 10 items of 1007 documents

Alzheimer’s disease and infections, where we stand and where we go

2014

Editorial Alzheimer’s disease (AD) is a progressive neurological disorder, which represents the most common form of dementia, one of the major causes of disability in later life. Age is the greatest risk factor for AD, which typically affects people aged 65 years and over, with an age-standardised prevalence of 4.4 [1]. However, AD is not a normal part of ageing and advanced age alone does not justify the disease. Several pathways have been implicated in AD pathophysiology, the most described is the neurodegenerative one, which lead to the brain accumulation of beta-amyloid and neurofibrillary tangles, aggregations of hyperphosphorylated tau protein, macroscopically resulting in brain atrop…

AgingTraumatic brain injuryImmunologyTau proteinperiodontal diseaseDiseaseInfectionsBioinformaticsAtrophyAlzheimer'MedicineDementiaRisk factorAlzheimer's; infections; herpes viruses; periodontal disease; infectionInflammationSettore MED/04 - Patologia Generalebiologybusiness.industryVascular diseaseHerpes virusesOdds ratiomedicine.diseaseinfectionAgeingEditorialImmunologybiology.proteinherpes viruseSettore MED/26 - NeurologiabusinessAlzheimer’s diseaseImmunity & Ageing
researchProduct

Methylprednisolone prevents nerve injury-induced hyperalgesia in neprilysin knockout mice.

2013

The pathophysiology of the complex regional pain syndrome involves enhanced neurogenic inflammation mediated by neuropeptides. Neutral endopeptidase (neprilysin, NEP) is a key enzyme in neuropeptide catabolism. Our previous work revealed that NEP knock out (ko) mice develop more severe hypersensitivity to thermal and mechanical stimuli after chronic constriction injury (CCI) of the sciatic nerve than wild-type (wt) mice. Because treatment with glucocorticoids is effective in early complex regional pain syndrome, we investigated whether methylprednisolone (MP) reduces pain and sciatic nerve neuropeptide content in NEP ko and wt mice with nerve injury. After CCI, NEP ko mice developed more se…

Agonistmedicine.medical_specialtymedicine.drug_classNeuropeptideSubstance PMethylprednisolonechemistry.chemical_compoundMiceInternal medicineMedicineAnimalsNeprilysinMice KnockoutNeurogenic inflammationbusiness.industryfungiNerve injuryMice Inbred C57BLAnesthesiology and Pain MedicineEndocrinologyNeuroprotective AgentsNeurologychemistryHyperalgesiaAnesthesiaHyperalgesiaNeprilysinNeurology (clinical)Sciatic nervemedicine.symptomSciatic NeuropathybusinessPainReferences
researchProduct

Application of C1-Esterase Inhibitor During Reperfusion of Ischemic Myocardium

2001

Background—Complement activation during reperfusion of ischemic myocardium augments myocardial injury, and complement inhibition with C1-esterase inhibitor (C1-INH) at the time of reperfusion exerts marked cardioprotective effects in experimental studies. Application of C1-INH in newborns, however, was recently reported to have dangerous and even lethal side effects. This study addresses the essential role of dosage in studies using C1-INH.Methods and Results—Cardioprotection by C1-INH was examined in a pig model with 60 minutes of coronary occlusion followed by 120 minutes of reperfusion. C1-INH was administered intravenously 5 to 10 minutes before coronary reperfusion without heparin at a…

Anaphylatoxinsmedicine.medical_specialtyNecrosisSwineHeart VentriclesPartial PressureMyocardial IschemiaIschemiaComplement C1 Inactivator ProteinsPharmacologyNecrosisTroponin TCoronary CirculationPhysiology (medical)Internal medicineAnimalsMedicineLactic AcidMyocardial infarctionCardiac OutputCreatine KinaseCardioprotectionDose-Response Relationship Drugbiologybusiness.industryMyocardiumHemodynamicsHeparinmedicine.diseaseComplement systemOxygenMicroscopy ElectronEndocrinologyCoronary occlusionEnzyme inhibitorReperfusion Injurybiology.proteinBlood Gas Analysismedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugCirculation
researchProduct

Optimising experimental research in respiratory diseases: an ERS statement

2018

Experimental models are critical for the understanding of lung health and disease and are indispensable for drug development. However, the pathogenetic and clinical relevance of the models is often unclear. Further, the use of animals in biomedical research is controversial from an ethical perspective.The objective of this task force was to issue a statement with research recommendations about lung disease models by facilitating in-depth discussions between respiratory scientists, and to provide an overview of the literature on the available models. Focus was put on their specific benefits and limitations. This will result in more efficient use of resources and greater reduction in the numb…

Animal Experimentation0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialtyBiomedical ResearchStatement (logic)Advisory CommitteeseducationMEDLINEDiseaseLung injury[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractHIGHLAND WHITE TERRIERSACUTE LUNG INJURY03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicineINBRED MOUSE STRAINSPulmonary fibrosisAnimalsHumansMedicineIntensive care medicineSocieties MedicalALLERGIC AIRWAY INFLAMMATIONbusiness.industryCOMMUNITY-ACQUIRED PNEUMONIACIGARETTE-SMOKE EXPOSURERespiration Disordersmedicine.diseaseDISTRESS-SYNDROME3. Good healthEuropeDisease Models Animal030104 developmental biologyANIMAL-MODELS030228 respiratory systemDrug developmentData qualityARTERIAL-HYPERTENSIONIDIOPATHIC PULMONARY-FIBROSISbusiness
researchProduct

Antioxidant activity and cardioprotective effect of a nonalcoholic extract of Vaccinium meridionale Swartz during ischemia-reperfusion in rats

2013

Our objective was to assess the antioxidant properties and the effects against the reperfusion injury of a nonalcoholic extract obtained by fermentation from the Colombian blueberry, mortiño (Vaccinium meridionale Swartz, Ericaceae). Antioxidant properties were assessed by in vitro systems. To examine the postischemic myocardial function, isolated rat hearts were treated 10 min before ischemia and during the first 10 min of reperfusion with the extract. To analyze the participation of nitric oxide (NO), other experiments were performed in the presence of nitric oxide synthase (NOS) inhibition with NG-nitro-L-arginine methyl ester (L-NAME). In cardiac tissue thiobarbituric acid reactive subs…

AntioxidantCIENCIAS MÉDICAS Y DE LA SALUDJuicesArticle Subjectmedicine.medical_treatmentNITRIC OXIDASE SYNTHASEPharmacologyEndothelial NOSFisiologíaNitric oxideAnthocyaninschemistry.chemical_compoundISCHEMIA-REPERFUSIONEnosANTIOXIDANTTBARSMedicineVACCINIUM MERIDIONALE SWCardioprotectionbiologybusiness.industry//purl.org/becyt/ford/3.1 [https]lcsh:Other systems of medicinelcsh:RZ201-999medicine.diseasebiology.organism_classificationNitric oxide synthaseMedicina BásicaComplementary and alternative medicineBiochemistrychemistryCiencias Médicasbiology.protein//purl.org/becyt/ford/3 [https]Anthocyanin degradationbusinessReperfusion injuryResearch Article
researchProduct

Drugs modulating the biological effects of peroxynitrite and related nitrogen species.

2007

The term “reactive nitrogen species” includes nitrogen monoxide, commonly called nitric oxide, and some other remarkable chemical entities (peroxynitrite, nitrosoperoxycarbonate, etc.) formed mostly from nitrogen monoxide itself in biological environments. Regardless of the specific mechanisms implicated in their effects, however, it is clear that an integrated pharmacological approach to peroxynitrite and related species is only just beginning to take shape. The array of affected chemical and pathological processes is extremely broad. One of the most conspicuous mechanisms observed thus far has been the scavenging of the peroxynitrite anion by molecules endowed with antioxidant activity. T…

AntioxidantChemistrymedicine.medical_treatmentGeneral MedicineOxidative phosphorylationFree Radical ScavengersLung injuryNitric OxideReactive Nitrogen SpeciesIn vitroAntioxidantsNitric oxidechemistry.chemical_compoundBiochemistryIn vivoPeroxynitrous AcidmedicineAnimalsHumansTyrosineReactive Oxygen SpeciesReactive nitrogen speciesPeroxynitriteDNA DamageMedicinal research reviews
researchProduct

Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart.

2003

INTRODUCTION: Melatonin (MEL), a pineal hormone, is well known as a potent antioxidant in a variety of ischemia-reperfusion models. Recent studies have assumed a pivotal role of reactive oxygen species (ROS) in the development of apoptosis. There are few pieces of information concerning a possible protective role of MEL against apoptosis in ischemia-reperfusion injury of myocardium. METHODS: We conducted an in vitro experiment: (1) to study the effect of MEL in the model of isolated and perfused working rat heart; (2) to evaluate the antioxidant capacity of MEL by a simple fluorescence test; and (3) to analyze the extent of apoptosis inhibition by MEL. Four groups of male Wistar rat were us…

Antioxidantmedicine.medical_treatmentIschemiaPharmacologymedicine.disease_causePathology and Forensic MedicineMelatonin03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesPhysiology (medical)medicineneoplasms030304 developmental biologychemistry.chemical_classification0303 health sciencesReactive oxygen speciesTUNEL assaymedicine.disease3. Good healthchemistryApoptosisAnesthesiaReperfusion injury030217 neurology & neurosurgeryOxidative stressmedicine.drugPathophysiology : the official journal of the International Society for Pathophysiology
researchProduct

Extravascular Lung Water Does Not Increase in Hypovolemic Patients after a Fluid-Loading Protocol Guided by the Stroke Volume Variation

2012

Introduction. Circulatory failure secondary to hypovolemia is a common situation in critical care patients. Volume replacement is the first option for the treatment of hypovolemia. A possible complication of volume loading is pulmonary edema, quantified at the bedside by the measurement of extravascular lung water index (ELWI). ELWI predicts progression to acute lung injury (ALI) in patients with risk factors for developing it. The aim of this study was to assess whether fluid loading guided by the stroke volume variation (SVV), in patients presumed to be hypovolemic, increased ELWI or not.Methods. Prospective study of 17 consecutive postoperative, fully mechanically ventilated patients dia…

Article Subjectbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aidCardiac indexHemodynamicslcsh:RC86-88.9Stroke volumeLung injuryCritical Care and Intensive Care MedicinePulmonary edemamedicine.diseaseHypovolemiaAnesthesiaClinical StudymedicineSinus rhythmmedicine.symptomComplicationbusinessCritical Care Research and Practice
researchProduct

Measurement of gas transport kinetics in high-frequency oscillatory ventilation (HFOV) of the lung using hyperpolarized 3He magnetic resonance imaging

2010

PURPOSE: To protect the patient with acute respiratory distress syndrome from ventilator associated lung injury (VALI) high-frequency oscillatory ventilation (HFOV) is used. Clinical experience has proven that HFOV is an efficient therapy when conventional artificial ventilation is insufficient. However, the optimal settings of HFOV parameters, eg, tidal volumes, pressure amplitudes and frequency for maximal lung protection, and efficient gas exchange are not established unambiguously. METHODS: In this work magnetic resonance imaging (MRI) with hyperpolarized (3)He was employed to visualize the redistribution of gas within the cadaver pig lung during HFOV. The saturated slice method was use…

Artificial ventilationARDSMaterials scienceVentilator-associated lung injurySwinemedicine.medical_treatmentKineticsHigh-Frequency VentilationHeliumOscillometryPressuremedicineAnimalsRadiology Nuclear Medicine and imagingLungRespiratory Distress SyndromeLungmedicine.diagnostic_testHigh-frequency ventilationApneaMagnetic resonance imagingModels Theoreticalmedicine.diseaseMagnetic Resonance ImagingRespiration ArtificialKineticsmedicine.anatomical_structureAnesthesiaGasesmedicine.symptomBiomedical engineeringJournal of Magnetic Resonance Imaging
researchProduct

Some aspects of cardiac antioxidant defence: Ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart

1990

Ebselcn (PZ 5 1 : 2-phenyl1.2-benzisoelenazol-3-( 2H)-one 1 is ii synthetic organoselenium compound with anti-inflammatory activity ( I . 21, which exhibits glutathione peroxidase (GSH-Px)-like activity, catalysing the reduction o f hydrogen peroxide as well as other organic peroxides [3-5]. Its antiinflammatory effect may be mediated by either the GSH-Px activity, the inhibition of leukotriene B4 formation [6], the antioxidant capacity, or a combination of all of them. Many attempts have been made to increase the antioxidant capacity of the myocardium, since free radical generation has been demonstrated in ischaemia-reperfusion damage [7, 81; superoxide dismutase (SOD) and catalase have be…

AzolesAntioxidantmedicine.medical_treatmentMyocardial Reperfusion InjuryIsoindolesPharmacologyBiochemistryAntioxidantsSuperoxide dismutaseSeleniumchemistry.chemical_compoundOrganoselenium CompoundsmedicineAnimalsHydrogen peroxidechemistry.chemical_classificationGlutathione PeroxidasebiologyChemistryEbselenMyocardiumGlutathione peroxidaseHeartRats Inbred StrainsGlutathioneRatsBiochemistryCatalasebiology.proteinPeroxidase
researchProduct